main content start

Video Shorts

Most Popular

Most Popular

Popular in No name
  • Breast Cancer3m 36s

    Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer

    Immune cells known as tumor-infiltrating lymphocytes (TILs) are thought to be a promising, affordable biomarker with prognostic and predictive potential.
    tumor-infiltrating lymphocytes (tils) promising biomarker
  • Myelodysplastic Syndromes4m 0s

    Selecting Right Patients for Early Initiation in HMAs in Low Risk MDS

    Selecting the right patients for early initiation of hypomethylating agents (HMAs) in low-risk MDS involves identifying those with progressive cytopenias, poor prognostic mutations, or high-risk features despite low-risk classification.
    hypomethylating agents (hmas) disease progression personalised treatment plans low risk mds
  • Myelodysplastic Syndromes2m 25s

    Factors that influence treatment adherence and outcomes in MDS

    Anticipate & manage adverse events to optimize treatment outcomes: Patients treated with hypomethylating agents are at increased risk of cytopenias & might need support with transfusions.
    adverse events hypomethylating agents mds treatment compliance
  • Breast Cancer3m 56s

    Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission

    There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
    her2 positive mbc prolonged remission trastuzumab duration
  • Multiple Myeloma4m 12s

    Key Practice Points -Myeloma Related Renal Impairment

    In patients with renal impairment primary goal is improvement of Renal Function which is associated with improved treatment outcomes. 50% of patients present renal impairment and renal impairment is severe in 15% of patients.
    myeloma renal impairment key practice points
  • Prostate Cancer2m 21s

    Role of Geriatric Assessment in prostate Cancer

    Average at diagnosis of prostate cancer is ~65 years & patients usually have multiple co- morbidities and may be on treatment with multiple prescribed medications.
    geriatric assessment prostate cancer
  • Multiple Myeloma2m 43s

    Practice Points: Management of Infections in Multiple Myeloma

    Patients with Multiple Myeloma and plasma cell disorders are at high risk of infections because of compromised immune system. Associated co morbidities can also increase susceptibility to certain infections.
    prophylaxis myeloma vaccination infections
  • Prostate Cancer3m 41s

    Whole genome sequencing in clinical practice

    Whole Genome Sequencing (Short)
    Whole Genome Sequencing is new tool for precision medicine in metastatic castration
    precision medicine prostate cancer whole genome sequencing
  • Oncology1m 36s

    Enhancing Global Access to Cancer Medicines

    Over the last decade we have seen emergence of increasing novel therapies like targeted therapy and immunotherapy & this has changed the natural history of disease for patients living with cancer including those with advanced disease.
    biosimilars access generics
  • Myelodysplastic Syndromes4m 34s

    Practical Approach for Using Iron Chelation Therapy in MDS

    Iron chelation therapy (ICT) in MDS is used to manage iron overload from frequent blood transfusions. It involves identifying patients who would benefit most, monitoring iron levels, and managing side effects of chelators
    iron chelation therapy (ict) iron overload risk reduction improved qol
  • Latest

    Latest

    Category Short Cards Listing

    All Videos

    All Videos

    Brightcove Tab Listing
    Sort by
    4m 34s
    Myelodysplastic...
    4m 0s
    Myelodysplastic...
    3m 11s
    Multiple Myeloma
    4m 12s
    Multiple Myeloma
    2m 41s
    OncoSpecials
    4m 19s
    Prostate Cancer
    Hi, can I help?
    Chat SupportX
    Support Team
    Hello, how can I help you today?
    Please select one of the below options.

    Find Information

    Unable to Login or Register

    Want to share feedback